Canaccord Genuity Group Increases Anpario (LON:ANP) Price Target to GBX 370

Anpario (LON:ANPFree Report) had its price objective hoisted by Canaccord Genuity Group from GBX 340 ($4.49) to GBX 370 ($4.89) in a report issued on Wednesday morning, MarketBeat Ratings reports. They currently have a buy rating on the stock.

Separately, Shore Capital reiterated a house stock rating on shares of Anpario in a research note on Wednesday, September 11th.

Read Our Latest Analysis on Anpario

Anpario Stock Performance

Shares of ANP opened at GBX 312.50 ($4.13) on Wednesday. The company has a current ratio of 5.13, a quick ratio of 5.16 and a debt-to-equity ratio of 0.23. The firm has a market cap of £52.84 million, a PE ratio of 1,736.11 and a beta of 0.57. Anpario has a 12 month low of GBX 220 ($2.91) and a 12 month high of GBX 340 ($4.49). The stock has a fifty day moving average price of GBX 288.06 and a 200-day moving average price of GBX 274.76.

Anpario Cuts Dividend

The business also recently declared a dividend, which will be paid on Friday, November 29th. Shareholders of record on Thursday, November 14th will be paid a dividend of GBX 3.25 ($0.04) per share. The ex-dividend date of this dividend is Thursday, November 14th. This represents a yield of 1.19%. Anpario’s payout ratio is 6,111.11%.

Anpario Company Profile

(Get Free Report)

Anpario plc, together with its subsidiaries, produces and distributes natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

See Also

Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.